Show simple item record

dc.contributor.authorQiu Zhao
dc.contributor.authorMin Xiao
dc.contributor.authorJian Ma
dc.contributor.authorCong Fu
dc.contributor.authorQianqian Gao
dc.contributor.authorYanzhi Bi
dc.contributor.otherDepartment of Oncology, Changzhou Tumor Hospital Affiliated to Soochow University, Changzhou, China
dc.contributor.otherDepartment of Oncology, Changzhou Tumor Hospital Affiliated to Soochow University, Changzhou, China
dc.contributor.otherDepartment of Oncology, Changzhou Tumor Hospital Affiliated to Soochow University, Changzhou, China
dc.contributor.otherDepartment of Oncology, Changzhou Tumor Hospital Affiliated to Soochow University, Changzhou, China
dc.contributor.otherDepartment of Pathology, Changzhou Tumor Hospital Affiliated to Soochow University, Changzhou, China
dc.contributor.otherDepartment of Oncology, Changzhou Tumor Hospital Affiliated to Soochow University, Changzhou, China
dc.date.accessioned2024-11-11T05:10:14Z
dc.date.available2025-10-02T05:34:59Z
dc.date.issued01-11-2024
dc.identifier.issn-
dc.identifier.urihttps://www.frontiersin.org/articles/10.3389/fonc.2024.1465664/full
dc.description.abstractAdvanced metastatic cardia cancer is an intractable malignance with poor prognosis. It is often accompanied by upper digestive tract obstruction, which seriously affects the quality of patients. Therefore, effective relief of eating obstruction is an important goal in the treatment of cardia cancer. Immune checkpoint inhibitors (ICIs) have shown significant efficacy in cardia cancer, but only a small percentage of patients will benefit from them due to immune resistance. Oncolytic viruses have been shown to enhance the efficacy of ICIs by altering the immune microenvironment. This indicates that oncolytic virus has the potential value of overcoming the immune resistance of cardia cancer. Here, we present a case with local recurrent and multiple metastatic cardia cancer accompanied by eating obstruction. After 4 cycles of chemotherapy plus ICI therapy, the patient´s metastases were significant shrink, but the recurrent carida lesion were almost unchanged. Then we implemented exploratory local injection of recombinant human adenovirus type 5(H101) into recurrent cardia lesion by painless gastroscopy. Surprisingly, the cardia lesion shrank significantly, and the eating obstruction was greatly relieved. We also observed a significant increase of infiltrated CD4+T cells in biopsy tissues after H101 treatment. Our study not only conformed the value of oncolytic viruses to reverse ICI resistance in patients with gastric cancer, but also revealed its underlying impact on immune microenvironment.
dc.format-
dc.language.isoEN
dc.publisherFrontiers Media S.A.
dc.relation.uri['http://journal.trunojoyo.ac.id/rechtidee/', 'http://journal.trunojoyo.ac.id/rechtidee/about/submissions#authorGuidelines', 'http://journal.trunojoyo.ac.id/rechtidee/about/editorialPolicies#focusAndScope']
dc.rightsCC BY-SA
dc.subject['civil law', 'criminal law', 'government', 'social science', 'Law in general. Comparative and uniform law. Jurisprudence', 'K1-7720']
dc.subject.lccNeoplasms. Tumors. Oncology. Including cancer and carcinogens
dc.titleReverse resistance to immune checkpoint inhibitor in a patient with recurrent cardia cancer by intratumoral injection of recombinant human adenovirus type 5: a case report and literature review
dc.typeArticle
dc.description.keywordscardia cancer
dc.description.keywordsimmune checkpoint inhibitors
dc.description.keywordsrecombinant human adenovirus type 5
dc.description.keywordsCD4+ T cell
dc.description.keywordsCD8+ T cell
dc.description.keywordsimmune microenvironment
dc.description.pages-
dc.description.doi10.3389/fonc.2024.1465664
dc.title.journalFrontiers in Oncology
dc.identifier.e-issn2234-943X
dc.identifier.oaioai:doaj.org/journal:0b467cdef52d422a876cf714ae066e33
dc.journal.info-


This item appears in the following Collection(s)

Show simple item record